GSK3B and non-small cell lung carcinoma: In addition, after knockout of GSK3β, the protein level of β-catenin was inconsistent in the lung adenocarcinoma cells, suggesting that in NSCLC cells, the expressions of β-catenin is regulated in a cell-type specific manner.